Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.35% -0.08% 686.32M 62013.40
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0% 39.00% -4.703M Upgrade

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the health care equipment and supplies segment of a U.S. total market composite index. In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index ("S&P TMI").
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Prospectus Benchmark Index
S&P HealthCare Equip Sel Industry TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Michael Feehily 10.09 yrs
Karl Schneider 7.09 yrs
Kala O’Donnell 4.91 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 43
-4.703M
-4.455B Category Low
4.573B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of November 30, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of December 06, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2014
2015
2016
2017
2018
2019
2020
YTD
15.97%
10.04%
11.78%
30.50%
8.91%
22.31%
32.91%
-0.84%
4.94%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
17.43%
44.98%
13.58%
-15.45%
43.77%
-15.27%
32.56%
48.33%
-22.14%
11.13%
20.27%
1.67%
34.87%
9.15%
20.17%
31.47%
0.79%
--
27.86%
-27.83%
45.63%
-11.71%
50.30%
21.17%
-21.32%
--
--
--
36.93%
-12.24%
39.64%
52.91%
-22.39%
As of December 06, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (12-7-21) 0%
30-Day SEC Yield (12-6-21) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 32.68
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 06, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 06, 2021

Asset Allocation

As of December 06, 2021.
Type % Net % Long % Short
Cash 0.04% Upgrade Upgrade
Stock 99.96% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
iRhythm Technologies Inc 2.89% 99.58 1.99%
Conmed Corp 1.60% 142.44 3.23%
Steris PLC 1.53% 228.32 1.26%
Tandem Diabetes Care Inc 1.52% 139.38 6.39%
Cerus Corp 1.49% 7.06 8.28%
Ortho Clinical Di.
1.49% -- --
Hill-Rom Holdings Inc 1.47% 155.89 0.10%
Abbott Laboratories 1.46% 132.42 -0.04%
Lantheus Holdings Inc 1.46% 27.84 4.54%
Masimo Corp 1.46% 282.98 0.89%

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the health care equipment and supplies segment of a U.S. total market composite index. In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index ("S&P TMI").
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Category Index S&P 1500 Health Care TR
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Prospectus Benchmark Index
S&P HealthCare Equip Sel Industry TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Michael Feehily 10.09 yrs
Karl Schneider 7.09 yrs
Kala O’Donnell 4.91 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (12-7-21) 0%
30-Day SEC Yield (12-6-21) Upgrade
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 32.68
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of December 06, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of December 06, 2021

Fund Details

Key Dates
Inception Date 1/26/2011
Last Annual Report Date 6/30/2021
Last Prospectus Date 10/31/2021
Attributes
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No